Advertisement
Research Article| Volume 56, 103254, November 2021

Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients

  • Alexis A Lizarraga
    Correspondence
    Corresponding author at: SUNY Buffalo Department of Neurology, 1010 Main St, 2nd Floor, Buffalo NY 14202, USA
    Affiliations
    Department of Neurology, University of Miami, Miami, FL, USA, 1120 NW 14th Street, 13th Floor, Miami FL 33136, USA

    Jacobs Multiple Sclerosis Center for Treatment and Research, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York (SUNY), Buffalo, NY, USA, 1010 Main St, 2nd Floor, Buffalo NY 14202, USA
    Search for articles by this author
  • Kottil W Rammohan
    Affiliations
    Department of Neurology, University of Miami, Miami, FL, USA, 1120 NW 14th Street, 13th Floor, Miami FL 33136, USA
    Search for articles by this author
  • Bianca Weinstock-Guttman
    Affiliations
    Jacobs Multiple Sclerosis Center for Treatment and Research, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York (SUNY), Buffalo, NY, USA, 1010 Main St, 2nd Floor, Buffalo NY 14202, USA
    Search for articles by this author
  • Khema Sharma
    Affiliations
    Department of Neurology, University of Miami, Miami, FL, USA, 1120 NW 14th Street, 13th Floor, Miami FL 33136, USA
    Search for articles by this author
Published:September 04, 2021DOI:https://doi.org/10.1016/j.msard.2021.103254

      Highlights

      • The prevalence of electrodiagnostic abnormalities, especially axonal polyneuropathy, in the MS population may be higher than previously considered.
      • The presence of a peripheral axonal polyneuropathy may be important in the context of central axonopathy and neurodegeneration in MS.
      • Sympathetic autonomic nervous system dysfunction is common in MS

      Abstract

      Background

      Peripheral nervous system (PNS) abnormalities in Multiple Sclerosis (MS) have been reported in case reports and small case series over the past several decades. Little is known, however, about the prevalence of electrodiagnostic abnormalities in patients with MS, including not only demyelinating neuropathies such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but also axonal peripheral neuropathy and sympathetic dysfunction.

      Methods

      This is an observational, cross-sectional study with the objective of identifying the prevalence of the electrodiagnostic abnormalities in predominantly Hispanic MS patients in Miami, Florida. Electrodiagnostic data including nerve conduction study (NCS), electromyography (EMG) and sympathetic skin response (SSR) information was prospectively collected in 18 patients (16 females; 43.7±15.2 years) with a diagnosis of MS compared to 18 healthy (16 females; 39.9±11 years), age- and height-matched controls. The study was offered to all-comers in the MS Clinic over a period of 3 months, regardless of clinical suspicion for an underlying neuropathic process, in an effort to estimate the prevalence of abnormalities. Demographic data including age, sex, race/ethnicity was evaluated in addition to MS-specific characteristics including MS subtype, duration of disease, duration of therapy, clinical symptoms and laboratory data.

      Results

      There were no significant differences in baseline characteristics of patients and controls for age (p=0.4) and height (164.0±6.4 vs 162.3±4.6 centimeters; p=0.3). The mean disease duration was 106±27 months (median 107 months; range 5-336 months). The mean Expanded Disability Status Scale (EDSS) was 2.4±1.87 (median: 2.5; range 1.0-6.5). The ethnicity of patients (15 Hispanic, 3 non-Hispanic) and controls (13 Hispanic, 5 non-Hispanic; p=0.56) was similar. The frequency of electrophysiological axonal polyneuropathy (PN) was 77.8% (14/18 patients), and 85.6% of these patients had clinical sensory symptoms. Interestingly, 1 patient had previously unrecognized CIDP. All 18 patients displayed prolonged SSR latencies consistent with autonomic dysfunction. Thirteen patients (72.2%) reported autonomic symptoms such as bladder abnormalities and blood pressure fluctuations.

      Conclusion

      The prevalence of electrodiagnostic abnormalities, especially axonal polyneuropathy, in the MS population may be higher than traditionally considered. The relationship between axonal polyneuropathy and central axonopathy in the context of neurodegeneration in MS should be further explored. Analytic studies may identify common symptomatic and pathophysiologic etiologies to further understanding and potentially guide treatment of MS subtypes with PNS involvement.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Antonini G
        • Millefiorini E
        • Borsellino G
        • et al.
        Subclinical peripheral nervous system involvement in multiple sclerosis.
        Muscle Nerve. 1995; : 1216-1217
        • Cortese A
        • Franciotta D
        • Alfonsi E
        • et al.
        Combined central and peripheral demyelination: clinical features, diagnostic findings and treatment.
        J. Neurol. Sci. 2016; 363: 182-187
        • Cortez MM
        • Nagi Reddy SK
        • Goodman B
        • Carter JL
        • Wingerchuk DM
        Autonomic symptom burden is associated with MS-related fatigue and quality of life.
        Mult. Scler. Relat. Disord. 2015; 4: 258-263
        • Elie B
        • Louboutin JP.
        Sympathetic skin response (SSR) is abnormal in multiple sclerosis.
        Muscle Nerve. 1995; 18: 185-189
        • Flachenecker P
        • Reiners K
        • Krauser M
        • Wolf A
        • Toyka KV.
        Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.
        Mult. Scler. J. 2001; 7: 327-334
        • Gartzen K
        • Katzarava Z
        • Diener HC
        • Putzki N.
        Peripheral nervous system involvement in multiple sclerosis.
        Eur. J. Neurol. 2011; 18: 789-791
        • Giovannoni G
        • Cutter G
        • Sormani MP
        • et al.
        The case for therapeutic lag and the asynchronous progressive MS hypotheses.
        Mult. Scler. Relat. Disord. 2017; 12: 70-78
        • Hadjixenofontos A
        • Beecham AH
        • Manrique CP
        • et al.
        Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry.
        Neuroepidemiology. 2015; 44: 262-268
        • Jende JME
        • Hauck GH
        • Diem R
        • et al.
        Peripheral nerve involvement in multiple sclerosis: Demonstration by magnetic resonance neurography.
        Ann. Neurol. 2017; 82: 676-685
        • Kawamura N
        • Yamasaki R
        • Yonekawa T
        • et al.
        Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
        Neurology. 2013; 81: 714-722
        • Lambe J
        • Fitzgerald KC
        • Murphy OC
        • et al.
        Association of Spectral-Domain OCT with long-term disability worsening in Multiple Sclerosis.
        Neurology. March 2021; (PMID: 33653904)
        • Løseth S
        • Nebuchennykh M
        • Stålberg E
        • Mellgren SI.
        Medial plantar nerve conduction studies in healthy controls and diabetics.
        Clin. Neurophysiol. 2007; 118 (May): 1155-1161
        • Ogata H
        • Matsuse D
        • Yamasaki R
        • et al.
        A nationwide survey of combined central and peripheral demyelinating in Japan.
        J. Neurol. Neurosurg. Psychiatry. 2016; 87: 29-36
        • Poser CM.
        The peripheral nervous system in multiple sclerosis. A review and pathogenetic hypothesis.
        J. Neurol. Sci. 1987; 79: 83-90https://doi.org/10.1016/0022-510x(87)90262-0
        • Racosta JM
        • Kimpinski K
        • Morrow SA
        • Kremenchutzky M.
        Autonomic dysfunction in multiple sclerosis.
        Auton. Neurosci. 2015; 193 (PMID: 26070809): 1-6
        • Saari A
        • Tolonen U
        • Pääkkö E
        • et al.
        Sympathetic skin responses in multiple sclerosis.
        Act Neurol. Scand. 2008; 118: 226-231
        • Sarova-Pinhas I
        • Achiron A
        • Gilad R
        • Lampl Y.
        Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study.
        Acta Neurol. Scand. 1995; 91: 234-238
        • Sharma KR
        • Saadia D
        • Facca AG
        • Bhatia R
        • Ayyar DR
        • Sheremata W.
        Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
        J. Clin. Neuromusc Dis. 2008; 9: 385-396
        • Sharma KR
        • Saadia D
        • Facca AG
        • Resnick S
        • Ayyar DR.
        Diagnostic role of deep tendon reflex latency measurement in small-fiber neuropathy.
        J. Peripher. Nerv. Syst. 2007; 12: 223-231
        • Sharma KR
        • Cross J
        • Ayyar DR
        • Shebert RT
        • Farronay O
        • Bradley WG.
        Demyelinating neuropathy in diabetes mellitus.
        Arch. Neurol. 2002; 59: 758-765
        • Sharma KR
        • Rotta F
        • Romano J
        • Ayyar DR.
        Early diagnosis of carpal tunnel syndrome: comparison of digit one to wrist and distoproximal ratio.
        Clin. Neurophysiol. 2001. 2001; : 2-10
        • Sharma KR
        • Romano JG
        • Ayyar DR
        • Facca AG
        • Sanchez-Ramos J.
        Sympathetic skin response and heart rate variability in patients with Huntington’s disease.
        Arch. Neurol. 1999; 56: 1248-1252
        • Suanprasert N
        • Taylor BV
        • Klein CJ
        • et al.
        Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
        MS Rel. Dis. 2019; 30: 284-290
        • Sullivan JP
        • Logigian EL
        • Kocharian N
        • Herrmann DN.
        Yield of the sural/radial ratio versus the medial plantar nerve in sensory neuropathies with a normal sural response.
        J. Clin. Neurophysiol. 2008; 25 (Apr): 111-114
        • Thomas PK
        • Walker RW
        • Rudge P
        • et al.
        Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination.
        Brain. 1987; 110: 53-76
        • Thompson A
        • Banwell B
        • Barkoff F
        • et al.
        Diagnosis of multiple sclerosis: 2017 revisions of the McDonald Criteria.
        Lancet Neurol. 2018; 17: 162-173
        • Van den Bergh PY
        • Hadden RD
        • Bouche P
        • et al.
        European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision [published correction appears in Eur J Neurol. 2011 May;18(5):796].
        Eur. J. Neurol. 2010; 17: 356-363
        • Vaughn CB
        • Kavak KS
        • Dwyer MG
        • et al.
        New York State Multiple Sclerosis Consortium. Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium.
        Mult. Scler. 2020; 26 (JanPMID: 30507270): 99-108
        • Zee PC
        • Cohen BA
        • Walczak T
        • Jubelt B.
        Peripheral nervous system involvement in multiple sclerosis.
        Neurology. 1991; 41 (457-46)